Nanoparticle-enabled molecular imaging diagnosis of osteoarthritis
Source abstract
Abstract
Osteoarthritis (OA) is the most common type of arthritis and affects patients with chronic pain, while imposing a heavy burden on public health systems worldwide. Current imaging technologies such as X-ray, MRI, and CT assist the diagnosis and monitoring of OA by providing anatomical pathological information. However, given the complex nature and progression of OA, conventional imaging technologies are limited in the molecular pathological information they are able to present and identify from the various health conditions of OA patients. Thus, nanoparticle-assisted imaging is promising to revolutionize the diagnosis and monitoring of OA, improving the sensitivity and specificity of imaging by enhancing the detection of key biomarkers such as proteoglycans, glycosaminoglycans, type II and X collagen, and inflammatory factors. In this review, the anatomical and pathological characteristics of OA, existing imaging modalities for OA diagnosis, and recent advances in the development of functionalized nanoparticles for molecular imaging of OA are summarized, highlighting the specific roles of nanoparticles in targeting biomarker molecules in different stages of OA progression. Additionally, the combined fields of artificial intelligence (AI) and imaging technology are discussed, followed by an overview of current challenges and future development of nanoparticles for molecular imaging of OA.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photoacoustic and Ultrasonic Imaging · Osteoarthritis Treatment and Mechanisms · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Osteoarthritis: pathology, diagnosis, and treatment options
2. Beyond cartilage repair: the role of the osteochondral unit in joint Health and Disease10.1089/ten.teb.2018.0122 ↗
3. Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee10.3390/ijms22052619 ↗
4. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression10.3390/ijms16036093 ↗
5. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 202110.1016/S2665-9913(23)00163-7 ↗
6. Does this patient have hip osteoarthritis?: the rational clinical examination systematic review10.1001/jama.2019.19413 ↗
7. Diagnosis of osteoarthritis: imaging10.1016/j.bone.2011.11.019 ↗
8. Rheological properties of cartilage glycosaminoglycans and proteoglycans10.1021/acs.macromol.0c02709 ↗
9. Collagen type II: from biosynthesis to advanced biomaterials for cartilage engineering
10. Proteoglycans in articular cartilage and their contribution to chondral injury and repair mechanisms10.3390/ijms241310824 ↗
11. Ultra-small superparamagnetic iron oxide nanoparticles for intra-articular targeting of cartilage in early osteoarthritis10.1093/rb/rbad052 ↗
12. Deep learning applications in osteoarthritis imaging10.1007/s00256-023-04296-6 ↗
13. Use of machine learning in osteoarthritis research: a systematic literature review10.1136/rmdopen-2021-001998 ↗
14. Studying osteoarthritis with artificial intelligence applied to magnetic resonance imaging10.1038/s41584-021-00719-7 ↗
15. Cationic tantalum oxide nanoparticle contrast agent for micro computed tomography reveals articular cartilage proteoglycan distribution and collagen architecture alterations10.1016/j.joca.2023.11.020 ↗
16. Light-addressable nanoclusters of ultrasmall iron oxide nanoparticles for enhanced and dynamic magnetic resonance imaging of arthritis10.1002/advs.201901800 ↗
17. Atlas of individual radiographic features in osteoarthritis, revised10.1016/j.joca.2006.11.009 ↗
18. Anterior cruciate ligament tears and associated meniscal lesions: assessment at dual-detector spiral CT arthrography10.1148/radiol.2232011024 ↗
19. Role of ultrasonography in knee osteoarthritis10.1097/RHU.0000000000000436 ↗
20. Increased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans10.1097/MNM.0000000000000376 ↗
21. Ultrasonography of the late-stage knee osteoarthritis prior to total knee arthroplasty: comparison of the ultrasonographic, radiographic and intra-operative findings10.1038/s41598-018-35824-3 ↗
22. Assessment of quantitative [18F]sodium fluoride PET measures of knee subchondral bone perfusion and mineralization in osteoarthritic and healthy subjects10.1016/j.joca.2021.02.563 ↗
23. Current and future applications of fluorescence guidance in orthopaedic surgery10.1007/s11307-022-01789-z ↗
24. Obesity, inflammation, and immune system in osteoarthritis10.3389/fimmu.2022.907750 ↗
25. Osteoarthritis10.1038/s41572-025-00594-6 ↗
26. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes10.1186/ar4405 ↗
27. Recent advances in understanding the phenotypes of osteoarthritis10.12688/f1000research.20575.1 ↗
28. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association10.1002/art.1780290816 ↗
29. Biological aspects of early osteoarthritis10.1007/s00167-011-1705-8 ↗
30. Imaging and biochemical markers for osteoarthritis10.3390/diagnostics11071205 ↗
31. Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis10.1016/j.tips.2014.03.005 ↗
32. Macrophage polarization in the osteoarthritis pathogenesis and treatment10.1111/os.14302 ↗
33. Osteoarthritis10.1016/S0140-6736(19)30417-9 ↗
34. Early osteoarthritis: how to define, diagnose, and manage. A systematic review10.1016/j.eurger.2017.07.008 ↗
35. Osteoarthritis: pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
36. Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state10.1016/j.joca.2014.05.021 ↗
37. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?10.1016/j.joca.2011.12.003 ↗
38. The role of synovitis in osteoarthritis pathogenesis10.1016/j.bone.2012.02.012 ↗
39. Osteoarthritis as a disease of the cartilage pericellular matrix10.1016/j.matbio.2018.05.008 ↗
40. Macrophages regulate the progression of osteoarthritis10.1016/j.joca.2020.01.007 ↗
41. A roadmap to target interleukin-6 in osteoarthritis10.1093/rheumatology/keaa248 ↗
42. Elevated levels of TNF-α, IL-1β and IL-6 in the synovial tissue of patients with labral tear: a comparative study with hip osteoarthritis10.1186/s12891-020-03888-w ↗
43. Pathological progression of osteoarthritis: a perspective on subchondral bone10.1007/s11684-024-1061-y ↗
44. Bone matrix microdamage and vascular changes characterize bone marrow lesions in the subchondral bone of knee osteoarthritis10.1016/j.bone.2018.01.012 ↗
45. Biomarkers for osteoarthritis diseases10.3390/life12111799 ↗
46. Association between tissue-inflammation biomarkers and progression of osteoarthritis: evidence from the Rotterdam Study10.1016/j.joca.2015.02.108 ↗
47. The deterioration of calcified cartilage integrity reflects the severity of osteoarthritis—a structural, molecular, and biochemical analysis10.1096/fj.202101449R ↗
48. Bone marrow lesions detected by specific combination of MRI sequences are associated with severity of osteochondral degeneration10.1186/s13075-016-0953-x ↗
49. Osteochondral alterations in osteoarthritis10.1016/j.bone.2011.10.010 ↗
50. Value of biomarkers in osteoarthritis: current status and perspectives10.1136/annrheumdis-2013-203726 ↗
51. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort10.1186/s13075-016-0976-3 ↗
52. Osteoarthritis early-, mid- and late-stage progression in the rat medial meniscus transection model10.1002/jor.25969 ↗
53. Imaging in osteoarthritis10.1016/j.joca.2021.04.018 ↗
54. Nanoparticles with “K-edge” metals bring “color” in multiscale spectral photon counting X-ray imaging10.1021/acsnano.4c11724 ↗
55. Impact of the joint space width measurement method on the design of knee osteoarthritis studies10.1007/BF03324491 ↗
56. A review for automated classification of knee osteoarthritis using KL grading scheme for X-rays10.1007/s13534-024-00437-5 ↗
57. Kellgren and Lawrence system for classification of osteoarthritis
58. Knee osteoarthritis detection and classification using X-rays10.1109/ACCESS.2023.3276810 ↗
59. Radiological assessment of osteo-arthrosis10.1136/ard.16.4.494 ↗
60. Toward classification criteria for early osteoarthritis of the knee10.1016/j.semarthrit.2017.08.006 ↗
61. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis10.1002/art.21296 ↗
62. Teaming up to overcome challenges toward translation of new therapeutics for osteoarthritis10.1002/jor.25944 ↗
63. 2D versus 3D MRI of osteoarthritis in clinical practice and research10.1007/s00256-023-04309-4 ↗
64. Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research10.1148/rg.311105084 ↗
65. Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis10.1016/j.joca.2003.11.003 ↗
66. Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score)10.1016/j.joca.2011.05.004 ↗
67. Early diagnosis to enable early treatment of pre-osteoarthritis10.1186/ar3845 ↗
68. Evaluation of cartilage repair and osteoarthritis with sodium MRI10.1002/nbm.3280 ↗
69. Advanced MR imaging for knee osteoarthritis: a review on local and brain effects10.3390/diagnostics13010054 ↗
70. Sodium imaging of human body organs and extremities in vivo10.1148/radiology.167.2.3357970 ↗
71. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis10.1002/mrm.10389 ↗
72. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA10.1002/jmri.20556 ↗
73. A review of design criteria for cancer-targeted, nanoparticle-based MRI contrast agents
74. Targeted delivery of hesperetin to cartilage attenuates osteoarthritis by bimodal imaging with Gd2(CO3)3@PDA nanoparticles via TLR-2/NF-κB/Akt signaling10.1016/j.biomaterials.2019.03.018 ↗
75. Gadolinium-based contrast agents (GBCAs) for MRI: a benefit–risk balance analysis from a chemical, biomedical, and environmental point of view
76. Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity10.1021/am4010495 ↗
77. Exceedingly small iron oxide nanoparticles as positive MRI contrast agents10.1073/pnas.1620145114 ↗
78. CT and X-ray contrast agents: current clinical challenges and the future of contrast10.1016/j.actbio.2023.09.027 ↗
79. High atomic number nanoparticles to enhance spectral CT imaging aspects10.1039/D3MA00231D ↗
80. Computed tomography of subchondral bone and osteophytes in hip osteoarthritis: the shape of things to come?10.3389/fendo.2011.00097 ↗
81. Cationic carrier mediated delivery of anionic contrast agents in low doses enable enhanced computed tomography imaging of cartilage for early osteoarthritis diagnosis10.1021/acsnano.2c12376 ↗
82. Spectral CT imaging of human osteoarthritic cartilage via quantitative assessment of glycosaminoglycan content using multiple contrast agents10.1063/5.0035312 ↗
83. Osteoarthritis/inflammation in vitro detection using a hyaluronate-coated Au nano-contrast probe10.1021/acsanm.4c00657 ↗
84. Ultrasound contrast imaging: fundamentals and emerging technology
85. Ultrasound imaging in knee osteoarthritis: current role, recent advancements, and future perspectives10.3390/jcm13164930 ↗
86. Research progress of ultrasound in accurate evaluation of cartilage injury in osteoarthritis
87. Construction of smart inorganic nanoparticle-based ultrasound contrast agents and their biomedical applications10.1007/S11434-015-0829-5 ↗
88. Imaging of osteoarthritis (OA): what is new?10.1016/j.berh.2016.09.007 ↗
89. Diagnostic accuracy of grayscale, power Doppler and contrast-enhanced ultrasound compared with contrast-enhanced MRI in the visualization of synovitis in knee osteoarthritis10.1016/j.ejrad.2020.109392 ↗
90. Clinical translation of photoacoustic imaging10.1038/s44222-024-00240-y ↗
91. Recent advances in contrast-enhanced photoacoustic imaging: overcoming the physical and practical challenges10.1021/acs.chemrev.2c00627 ↗
92. Multispectral quantitative photoacoustic imaging of osteoarthritis in finger joints10.1364/AO.49.005721 ↗
93. Photoacoustic imaging of synovial tissue hypoxia in experimental post-traumatic osteoarthritis10.1016/j.pbiomolbio.2018.03.009 ↗
94. Noninvasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography10.1117/1.2192804 ↗
95. Early diagnosis and treatment of osteoarthritis with a Au@PDA-WL NP nano-probe by photoacoustic imaging10.1039/D3TB00760J ↗
96. Engineering plasmonic nanoparticles for enhanced photoacoustic imaging10.1021/acsnano.0c05215 ↗
97. Photoacoustic tomography: in vivo imaging from organelles to organs10.1126/science.1216210 ↗
98. Clinical spectrum and diagnostic pitfalls of multiple abnormal uptakes on bone scintigraphy10.1007/s11604-016-0585-8 ↗
99. Radionuclide bone imaging: an illustrative review10.1148/rg.232025103 ↗
100. Imaging of osteoarthritis-recent research developments and future perspective10.1259/bjr.20170349 ↗